Actively Recruiting
Familial Pancreatic Cancer PROPHilation Program in Italy
Led by Associazione Italiana per lo Studio del Pancreas · Updated on 2023-02-15
3000
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
Sponsors
A
Associazione Italiana per lo Studio del Pancreas
Lead Sponsor
G
General and Pancreatic Surgery Unit, University of Verona
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only. Participants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test. Up to 3,000 participants will be enrolled in this study.
CONDITIONS
Official Title
Familial Pancreatic Cancer PROPHilation Program in Italy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Being enrolled on the IRFARPC registry
- Having familiarity for pancreatic cancer (according to the IRFARPC criteria, Capurso et al. Dig Liv Dis, 2020)
- Willingness to participate in saliva-swab-based genetic testing
You will not qualify if you...
- Already known genetic mutation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chirurgia generale e del Pancreas Azienda Ospedaliera Universitaria Integrata
Verona, Italy, 37136
Actively Recruiting
Research Team
E
Erica Secchettin, PharmD
CONTACT
A
AISP Association
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here